Barclays’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.44M | Buy |
|
|||||
|
2025
Q1 | $3.27M | Sell |
|
|||||
|
2024
Q4 | $4.44M | Buy |
|
|||||
|
2024
Q3 | $3.39M | Buy |
|
|||||
|
2024
Q2 | $1.55M | Sell |
|
|||||
|
2024
Q1 | $2.75M | Sell |
|
|||||
|
2023
Q4 | $2.98M | Buy |
|
|||||
|
2023
Q3 | $1.51M | Buy |
|
|||||
|
2023
Q2 | $1.62M | Buy |
|
|||||
|
2023
Q1 | $1.64M | Buy |
|
|||||
|
2022
Q4 | $1.59M | Sell |
|
|||||
|
2022
Q3 | $1.72M | Buy |
|
|||||
|
2022
Q2 | $1.43M | Sell |
|
|||||
|
2022
Q1 | $2.17M | Sell |
|
|||||
|
2021
Q4 | $2.26M | Buy |
|
|||||
|
2021
Q3 | $1.67M | Buy |
|
|||||
|
2021
Q2 | $1.06M | Sell |
|
|||||
|
2021
Q1 | $2.79M | Sell |
|
|||||
|
2020
Q4 | $3.04M | Sell |
|
|||||
|
2020
Q3 | $3.24M | Buy |
|
|||||
|
2020
Q2 | $3.33M | Buy |
|
|||||
|
2020
Q1 | $1.68M | Buy |
|
|||||
|
2019
Q4 | $2.09M | Buy |
|
|||||
|
2019
Q3 | $1.69M | Sell |
|
|||||
|
2019
Q2 | $2.09M | Sell |
|
|||||
|
2019
Q1 | $2.86M | Buy |
|
|||||
|
2018
Q4 | $2.29M | Sell |
|
|||||
|
2018
Q3 | $4.08M | Buy |
|
|||||
|
2018
Q2 | $1.49M | Buy |
|
|||||
|
2018
Q1 | $1.11M | Buy |
|
|||||
|
2017
Q4 | $450K | Buy |
|
|||||
|
2017
Q3 | $133K | Sell |
|
|||||
|
2017
Q2 | $296K | Sell |
|
|||||
|
2017
Q1 | $247K | Buy |
|
|||||
|
2016
Q4 | $56K | Sell |
|
|||||
|
2016
Q3 | $501K | Sell |
|
|||||
|
2016
Q2 | $415K | Sell |
|
|||||
|
2016
Q1 | $335K | Sell |
|
|||||
|
2015
Q4 | $422K | Sell |
|
|||||
|
2015
Q3 | $1.52M | Buy |
|
|||||
|
2015
Q2 | $22K | Sell |
|
|||||
|
2015
Q1 | $175K | Buy |
|
|||||
|
2014
Q4 | $40K | Sell |
|
|||||
|
2014
Q3 | $135K | Buy |
|
|||||
|
2014
Q2 | $102K | Sell |
|
|||||
|
2014
Q1 | $225K | Buy |
|
|||||
|
2013
Q4 | $98K | Sell |
|
|||||
|
2013
Q3 | $129K | Buy |
|
|||||
|
2013
Q2 | $23K | Buy |
|